CPP

Critical Process Parameter

A critical process parameter is an input you control; a critical quality attribute is an output you need. The link between them is what process understanding actually means: a parameter earns the “critical” label because evidence shows its variation moves a CQA outside acceptable limits. Without that demonstrated relationship, designating a parameter critical is guesswork dressed as rigour.

Criticality is established through development work — designed experiments, mechanistic understanding, and risk assessment — not by opinion or by carrying over the previous product’s list. The output is a proven acceptable range for each CPP, and a control strategy that keeps the process inside it with monitoring, alarms, and defined responses when it drifts.

The same discipline that applies to CQAs applies here: if everything is critical, nothing is prioritised. Over-designating parameters produces an unmanageable control strategy, excessive deviations against limits that do not matter, and change-control friction with no quality benefit. Parameters that affect performance but not quality attributes are key process parameters — worth controlling, but not the same thing.

• —CPPs are inputs controlled to deliver CQAs, which are outputs.
• —Criticality must be demonstrated — usually through designed experiments and risk assessment.
• —Each CPP gets a proven acceptable range and a defined control and response.
• —Distinguish critical parameters from key parameters that affect performance but not quality.
• —Over-designation creates unmanageable control strategies and meaningless deviations.
• —CPPs and their ranges are the backbone of what is trended in continued process verification.

ICH Q8(R2) Pharmaceutical Development (definitions of CQA, CPP, design space); ICH Q11 for drug substance; ICH Q9(R1) for the risk assessment assigning criticality; FDA Process Validation guidance (2011) for the Stage 1 studies that establish it.